Clinical Trials for Pediatric Neuroblastoma

4 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
PreventionVICCPED12112
01/04/2013
NMTRC003: A Phase II Preventative Trial of DFMO (eflornithine HCI) as a Single Agent in Patients with High Risk Neuroblastoma in Remission
TreatmentCOGANBL12P1
06/05/2013
Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma
TreatmentVICCPED1249
08/06/2012
An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
TreatmentCOGADVL0912
04/05/2011
PH 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-MET, in Children With Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma

You do not have JavaScript enabled. This site works better with JavaScript turned on.